$GBCI

GLACIER BANCORP, INC.

No enriched coverage for $GBCI in the last 7 days.

No SEC Form 4 filings for $GBCI in the last 30 days.

Med

Stock Picks Under $50: Glacier Bancorp, Arlo Technologies, and Nutanix Analysis - News and Statistics

This article analyzes three stocks priced under $50: Glacier Bancorp, Arlo Technologies, and Nutanix. It advises caution on Glacier Bancorp due to slower net interest income growth, declining EPS despite revenue growth, and muted tangible book value growth. Conversely, Arlo Technologies is presented as a stock to watch due to solid revenue growth, increasing profitability, and strong free cash flow margin, while Nutanix is also highlighted as a stock to watch for its pioneering role in hyperconverged infrastructure.

3 Bank Stocks to Avoid: Glacier Bancorp, Citizens Financial, First Citizens BancShares - News and Statistics

Despite a generally positive outlook for the banking sector, three specific bank stocks—Glacier Bancorp (NYSE:GBCI), Citizens Financial Group (NYSE:CFG), and First Citizens BancShares (NASDAQGS:FCNC.A)—are identified as stocks to avoid. Concerns include subdued net interest income, lower-than-average revenue growth, and less profitable incremental sales compared to industry peers. Investors are advised to exercise caution due to these banks' vulnerabilities to interest rate changes and economic cycles.

M&T Bank Corp Reduces Stock Position in Glacier Bancorp, Inc. $GBCI

M&T Bank Corp significantly reduced its stake in Glacier Bancorp, Inc. by 84.7% in Q4, leaving them with 10,659 shares valued at $470,000. Despite this, other institutional investors increased their holdings. Glacier Bancorp reported strong Q4 earnings, beating estimates with an EPS of $0.70 and generating $306.8 million in revenue, while maintaining a quarterly dividend of $0.33.